Clinical Trial Update: Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating the TEX combination (docetaxel, oxaliplatin, capecitabine) for advanced or metastatic gastric c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED